CG Metalconstruct SPRL
The score of CG Metalconstruct shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2017
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CG Metalconstruct's annual accounts
| 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|
| Revenue | 12,000 € | |||
| Net result | 77,787 € | |||
| Equity | −43,173 € | |||
| Cash | 3,548 € | |||
| EBITDA | 80,667 € | |||
| Total assets | 313,575 € |
Filed annual accounts
- Year ended 31 Dec 2017filed on 03 Jul 2018
- Year ended 31 Dec 2016filed on 18 Jul 2017
- Year ended 31 Dec 2015filed on 12 Aug 2016
- Year ended 31 Dec 2014filed on 03 Jul 2015
CG Metalconstruct's financial analysis
- Solvency-13.8%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CG Metalconstruct
CG Metalconstruct's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0472.027.140
- VAT number
- BE0472027140
- Peppol
- Not found on Peppol as of 01 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 31 May 2000
- Registered office
- 7321 Bernissart
- Latest accounts
- 2017 · filed on 03 Jul 2018
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
CG Metalconstruct (SPRL) has been based in Bernissart since 2000, active in: manufacture of basic pharmaceutical products. For 2017, it reports revenue of 12,000 €, a net profit of 77,787 € and equity of −43,173 €. Its solvency stands at -13.8%, below the median of its sector (38.7%).
Companies similar to CG Metalconstruct
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Dutrannois Manufacture of basic pharmaceutical products Ath · balance sheet 290,974 €
- Genichem Manufacture of basic pharmaceutical products Tournai · balance sheet 274,088 €
- Cargo Consult AND Trade Manufacture of basic pharmaceutical products Tournai · balance sheet 194,937 €
- Bureau D'Architectes Marteleur ET Mauroy Manufacture of basic pharmaceutical products Mons · balance sheet 534,063 €
- Clarethis Manufacture of basic pharmaceutical products Soignies · balance sheet 172,781 €
- EFA Engineering Manufacture of basic pharmaceutical products Mouscron · balance sheet 167,137 €
- Sprl société médicale Docteur Tournay Yasmina Manufacture of basic pharmaceutical products Mons · balance sheet 589,598 €
- Cogeco Manufacture of basic pharmaceutical products Ath · balance sheet 158,889 €
Frequently asked questions about CG Metalconstruct
What is the revenue of CG Metalconstruct?
According to the 2017 annual accounts filed with the NBB, the revenue of CG Metalconstruct amounts to 12,000 €.
What is the VAT number of CG Metalconstruct?
In Belgium, the VAT number is the company number prefixed with BE: BE0472027140 for CG Metalconstruct, if the company is VAT-registered. Its company number (CBE) is 0472.027.140.
Where is the registered office of CG Metalconstruct?
According to the CBE register, the registered office of CG Metalconstruct is in 7321 Bernissart.
What is the equity of CG Metalconstruct?
At the close of the 2017 financial year, the equity of CG Metalconstruct amounts to -43,173 €, a solvency of -13.8% of total assets.
Who manages CG Metalconstruct?
The register lists 2 active mandates at CG Metalconstruct. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CG Metalconstruct
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →